Civeo - CVEO Stock Forecast, Price & News

Civeo's stock was trading at $31.10 at the beginning of 2023. Since then, CVEO stock has decreased by 36.8% and is now trading at $19.67.
View the best growth stocks for 2023 here.

Civeo saw a drop in short interest in the month of February. As of February 28th, there was short interest totaling 37,300 shares, a drop of 15.2% from the February 13th total of 44,000 shares. Based on an average daily trading volume, of 62,300 shares, the days-to-cover ratio is currently 0.6 days. Approximately 0.3% of the shares of the stock are short sold.
View Civeo's Short Interest.

The company is scheduled to release its next quarterly earnings announcement on Friday, May 5th 2023.
View our CVEO earnings forecast.

Civeo Co. (NYSE:CVEO) announced its quarterly earnings results on Thursday, October, 28th. The business services provider reported $0.03 EPS for the quarter, missing the consensus estimate of $0.25 by $0.22. The business services provider had revenue of $155.06 million for the quarter, compared to analyst estimates of $154.95 million. Civeo had a trailing twelve-month return on equity of 2.87% and a net margin of 0.57%. During the same period in the prior year, the business earned $0.36 earnings per share.

ETFs with the largest weight of Civeo (NYSE:CVEO) stock in their portfolio include Changebridge Capital Sustainable Equity ETF (CBSE), Changebridge Capital Long/Short Equity ETF (CBLS) and AdvisorShares Dorsey Wright Micro-Cap ETF (DWMC).

Civeo shares reverse split on Friday, November 20th 2020. The 1-12 reverse split was announced on Monday, November 9th 2020. The number of shares owned by shareholders was adjusted after the closing bell on Thursday, November 19th 2020. An investor that had 100 shares of stock prior to the reverse split would have 8 shares after the split.

Civeo issued an update on its FY 2023 earnings guidance on Tuesday, February, 28th. The company provided EPS guidance of for the period. The company issued revenue guidance of $630.00 million-$650.00 million, compared to the consensus revenue estimate of $662.32 million.

15 employees have rated Civeo Chief Executive Officer Bradley J. Dodson on Glassdoor.com. Bradley J. Dodson has an approval rating of 75% among the company's employees.

Based on aggregate information from My MarketBeat watchlists, some companies that other Civeo investors own include Novavax (NVAX), Co-Diagnostics (CODX), Livongo Health (LVGO), NVIDIA (NVDA), Alto Ingredients (PEIX), Sorrento Therapeutics (SRNE), Inovio Pharmaceuticals (INO), Maxar Technologies (MAXR), Marvell Technology (MRVL) and Boeing (BA).

Civeo trades on the New York Stock Exchange (NYSE) under the ticker symbol "CVEO."

Civeo's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Horizon Kinetics Asset Management LLC (28.23%), Horizon Kinetics Asset Management LLC (28.23%), Conversant Capital LLC (6.05%), Renaissance Technologies LLC (4.20%), Mad River Investors (2.51%) and Dimensional Fund Advisors LP (2.41%). Insiders that own company stock include Allan Schoening, Bradley J Dodson, Constance B Moore, Lance Torgerson, Martin Lambert and Peter Mccann.
View institutional ownership trends.

Shares of CVEO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of CVEO stock can currently be purchased for approximately $19.67.

Civeo (NYSE:CVEO) has a market capitalization of $299.38 million and generates $697.05 million in revenue each year. The business services provider earns $4 million in net income (profit) each year or ($0.39) on an earnings per share basis.

The company employs 1,400 workers across the globe.

Civeo's mailing address is THREE ALLEN CENTER 333 CLAY STREET SUITE 4980, HOUSTON TX, 77002. The official website for the company is www.civeo.com. The business services provider can be reached via phone at (713) 510-2400, via email at ir@civeo.com, or via fax at 713-510-2499.